tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)

DRUG2 trials

Sponsors

Astellas Pharma Europe B.V.

Conditions

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms

Phase 3

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

CompletedNCT01018511

Astellas Pharma Europe B.V.Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Start: 2010-01-11End: 2011-03-01Updated: 2024-12-03

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

CompletedNCT01021332

Astellas Pharma Europe B.V.Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Start: 2010-04-26End: 2011-12-14Updated: 2024-12-03